The Biggest Psychedelic News This Week – October 9th
Weekly psychedelic news: Psychedelics could treat OCD, Novartis abandons study and Cybin Inc moves to acquire Small Pharma
Weekly psychedelic news: Psychedelics could treat OCD, Novartis abandons study and Cybin Inc moves to acquire Small Pharma
Psychedelic news: PTSD treatments, Esketamine’s efficacy, Eureka’s decrim, and PsyCan’s proposal. Stay informed on the latest updates.
Psychedelic News: California’s Bill 58 updates, SSRIs and DMT for depression, Maine’s pivotal moments, and Brazil’s opinions on psychedelics.
Psychedelic News Surge: Massachusetts’ Plant Medicine Dive, Kentucky’s Ibogaine Initiative, Pain-Relieving Potential, and Ketamine’s Pediatric Promise
A Canadian study found significant reductions in substance use after taking psychedelics, including alcohol and cocaine.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.